Olfr735 Inhibitors
Olfr735, a member of the olfactory receptor family 4 subfamily Q (OR4Q), plays a fundamental role in the olfactory system of Mus musculus (house mouse). These olfactory receptors are integral to the detection and discrimination of various odorant molecules within the nasal cavity. Olfr735, like other olfactory receptors, belongs to the extensive family of G-protein-coupled receptors (GPCRs), characterized by a seven-transmembrane domain structure. This unique receptor family is responsible for recognizing odorants and transmitting signals through G protein-mediated pathways, ultimately leading to the perception of distinct smells. The olfactory receptor gene family is notably the largest in the mouse genome, highlighting the significance of olfaction in the mouse's sensory perception.
Inhibiting Olfr735 involves intricate mechanisms that can be achieved through direct or indirect means. Direct inhibition occurs when specific chemical compounds interact with Olfr735, disrupting its ability to recognize and respond to odorant molecules. These inhibitors can bind to the receptor, altering its conformation and preventing its activation by odorants. Alternatively, indirect inhibition targets the signaling pathways associated with Olfr735's function. Chemicals in this category modulate intracellular pathways, such as the cyclic AMP (cAMP) signaling cascade, which is crucial for olfactory signal transduction. By influencing these pathways, indirect inhibitors can alter the receptor's responsiveness to odorants, effectively inhibiting Olfr735. This comprehensive understanding of Olfr735's inhibition mechanisms allows us to delve into the intricate world of olfaction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-adrenergic receptor antagonist. By blocking these receptors, it can reduce the levels of cyclic AMP (cAMP), a secondary messenger in GPCR signaling. Lower cAMP levels might indirectly reduce Olfr735 signaling, as cAMP is often involved in olfactory receptor signaling pathways. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Carvedilol is a non-selective beta-blocker with alpha-1 blocking activity. It lowers cAMP levels by inhibiting adrenergic receptors, which can indirectly affect GPCR-mediated signaling pathways including those involving olfactory receptors like Olfr735. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist. By inhibiting these receptors, it can increase neurotransmitter release, potentially altering GPCR signaling cascades, including those related to Olfr735, by modulating the cellular context of the receptor's activation. | ||||||
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Ketanserin is a selective 5-HT2A serotonin receptor antagonist. It modifies serotonin signaling, potentially affecting GPCR-mediated pathways, including those involving olfactory receptors, due to the widespread role of serotonin in modulating neuronal signaling. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine is an atypical antipsychotic that acts as a serotonin-dopamine antagonist. This drug affects multiple neurotransmitter systems and could indirectly impact GPCR signaling, including olfactory receptors, by altering neurotransmitter levels and receptor availability. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a dopamine antagonist primarily used as an antipsychotic. It influences dopamine pathways, which could indirectly affect GPCR signaling including olfactory receptors by modulating dopaminergic activity. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $174.00 $719.00 $1020.00 $2040.00 | 1 | |
Risperidone is an antipsychotic drug that acts as a dopamine and serotonin antagonist. It affects multiple neurotransmitter systems, potentially impacting GPCR signaling pathways, including those of olfactory receptors, by altering the neurochemical environment. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron is a serotonin 5-HT3 receptor antagonist. It modulates serotonin signaling, potentially affecting GPCR-mediated pathways, including olfactory receptor pathways, by altering the serotonergic system. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Atenolol is a selective beta1-adrenergic receptor antagonist. By specifically targeting beta1 receptors, it could indirectly influence GPCR signaling pathways, including olfactory receptors, by modulating adrenergic activity and cAMP levels. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $107.00 $243.00 | 3 | |
Metoprolol is a beta1-adrenergic receptor blocker. Its selective action on beta1 receptors could indirectly affect GPCR signaling, including Olfr735, by altering cAMP levels and adrenergic signaling dynamics. | ||||||